TerrAscend Corp. (TSNDF) Financials

TSNDF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 553.7 million 469.7 million
March 31, 2026 549.1 million 458.2 million
Dec. 31, 2025 557.4 million 458.4 million
Sept. 30, 2025 555.3 million 459.8 million

TSNDF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 4.9 million 829000
March 31, 2026 7.6 million 885000
Dec. 31, 2025 6.4 million 1.3 million
Sept. 30, 2025 613276 1.4 million

TSNDF Net Income

No data available :(

TSNDF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 42.0 million 199.3 million 30.0 million
March 31, 2026 39.6 million 212.7 million 30.8 million
Dec. 31, 2025 37.8 million 210.7 million 30.1 million
Sept. 30, 2025 37.5 million 211.9 million 31.8 million

TSNDF Shares Outstanding

No data available :(

TSNDF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.6 million - 22.9 million 1.6 million
March 31, 2026 853016 - 20.6 million 1.5 million
Dec. 31, 2025 1.7 million - 28.0 million 16.4 million
Sept. 30, 2025 3.1 million - 21.3 million 1.0 million

TSNDF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 65.4 million 31.3 million
March 31, 2026 65.5 million 30.9 million
Dec. 31, 2025 59.5 million 27.1 million
Sept. 30, 2025 65.1 million 31.2 million

TSNDF

Price: $0.51

52 week price:
0.35
1.45

Payout Ratio Range:
-24.44%
10.82%

Earnings Per Share: 0.04 USD

P/E Ratio: 15.88

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 197.0 million

Links: